Cited by 662Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

Open access

Adabag, A. Selcuk, Maron, Barry J., Appelbaum, Evan, Harrigan, Caitlin J., Buros, Jacqueline L., Gibson, C. Michael, Lesser, John R., Hanna, Constance A., Udelson, James E., Manning, Warren J., Maron, Martin S.·2008·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2007.11.071

Open this paper in CoChat — free account Open PDF

Abstract

Objectives Our aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic resonance (CMR), represents an arrhythmogenic substrate in hypertrophic cardiomyopathy (HCM).Background Myocardial fibrosis is identified frequently in HCM; however, the clinical significance of this finding is uncertain.Methods We studied prevalence and frequency of tachyarrhythmias on 24-h ambulatory Holter electrocardiogram (ECG) with regard to delayed enhancement (DE) on contrast-enhanced CMR in 177 HCM patients (age 41 +/- 16 yrs; 95% asymptomatic or mildly symptomatic).Results Premature ventricular contractions (PVCs), couplets, and nonsustained ventricular tachycardia (NSVT) were more common in patients with DE than those without DE (PVCs: 89% vs. 72%; couplets: 40% vs. 17%; NSVT: 28% vs. 4%; p < 0.0001 to 0.007). Patients with DE also had greater numbers of PVCs (202 +/- 655 vs. 116 +/- 435), couplets (1.9 +/- 5 vs. 1.2 +/- 10), and NSVT runs (0.4 +/- 0.8 vs. 0.06 +/- 0.4) than non-DE patients (all p < 0.0001); DE was an independent predictor of NSVT (relative risk 7.3, 95% confidence interval 2.6 to 20.4; p < 0.0001). However, extent (%) of DE was similar in patients with and without PVCs (8.2% vs. 9.1%; p = 0.93), couplets (8.5% vs. 8.4%; p = 0.99), or NSVT (8.3% vs. 8.5%; p = 0.35).Conclusions In this large HCM cohort with no or only mild symptoms, myocardial fibrosis detected by CMR was associated with greater likelihood and increased frequency of ventricular tachyarrhythmias (including NSVT) on ambulatory Holter ECG. Therefore, contrast-enhanced CMR identifies HCM patients with increased susceptibility to ventricular tachyarrhythmias.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2007.11.071

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
Kim, R. J., Wu, E., Rafael, A., Chen, E.-L., Parker, M. A., Simonetti, O. P., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432003 · Cited by 3,308
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function
Kim, R. J., Fieno, D. S., Parrish, T. B., Harris, K. R., Chen, E.-L., Simonetti, O. P., Bundy, J. M., Finn, J. P., Klocke, F. J., & Judd, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.19.1992 · Cited by 2,583
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
Self-citation
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572
Self-citation
Sudden Death in Young Athletes
Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394
Self-citation
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy
Grothues, F., Smith, G. C., Moon, J. C. C., Bellenger, N. G., Collins, P., Klein, H. U., & Pennell, D. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02381-0 · Cited by 1,267
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, R. G., Prasad, S. K., Lyne, J. C., Smith, G., Burman, E., KHAN, M. G., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,163
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
Mahrholdt, H., Wagner, A., Judd, R. M., Sechtem, U. P., & Kim, R. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi258 · Cited by 914
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Self-citation

Flagged first, then by citations

Show all 43 references

Sorted by citations

Items 101–200 of 661

Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers
Lyon, A., Ariga, R., Mincholé, A., Mahmod, M., Ormondroyd, E., Laguna, P., de Freitas, N., Neubauer, S., Watkins, H. C., & Rodríguez, B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00213 · Cited by 85
Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy
Maron, M. S., & Maron, B. J. (2015) · Circulation · doi:10.1161/circulationaha.114.014283 · Cited by 84
Self-citation
Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis
Olivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.9 · Cited by 85
Significance of left ventricular apical–basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy
Gruner, C., Chan, R. H. M., Crean, A. M., Rakowski, H., Rowin, E. J., Care, M. E., Deva, D. P., Williams, L. K., Appelbaum, E. A., Gibson, C. M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu154 · Cited by 84
Self-citation
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.019 · Cited by 85
Self-citation
Risk Stratification and Role of Implantable Defibrillators for Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy
Maron, B. J. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0921 · Cited by 84
Self-citation
The Hypertensive Heart
Raman, S. V. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.059 · Cited by 79
Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights
Silbiger, J. J. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.03.003 · Cited by 79
How to Image Hypertrophic Cardiomyopathy
Maron, M. S., Rowin, E. J., & Maron, B. J. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005372 · Cited by 70
Self-citation
MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside
Bogaert, J. G., & Olivotto, I. (2014) · Radiology · doi:10.1148/radiol.14131626 · Cited by 78
Intermediate-Signal-Intensity Late Gadolinium Enhancement Predicts Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy
Appelbaum, E. A., Maron, B. J., Adabağ, S., Hauser, T. H., Lesser, J. R., Haas, T. S., Riley, A. B., Harrigan, C. J., Delling, F. N., Udelson, J. E., et al. (2011) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.963819 · Cited by 74
Self-citation
Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease
Fogel, M. A., Anwar, S., Broberg, C. S., Browne, L. P., Chung, T., Johnson, T. R., Muthurangu, V., Taylor, M. D., Valsangiacomo-Buechel, E., & Wilhelm, C. M. (2022) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-022-00843-7 · Cited by 83
Aortic Stiffness Is Increased in Hypertrophic Cardiomyopathy With Myocardial Fibrosis
Boonyasirinant, T., Rajiah, P. S., Setser, R. M., Lieber, M. L., Lever, H. M., Desai, M. Y., & Flamm, S. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.060 · Cited by 75
Long-Term Prognostic Value of Dobutamine Stress CMR
Kelle, S., Chiribiri, A., Vierecke, J. K., Egnell, C., Hamdan, A., Jahnke, C., Paetsch, I., Wellnhofer, E., Fleck, E., Klein, C., et al. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.11.012 · Cited by 74
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.048 · Cited by 74
Self-citation
Improvement of late gadolinium enhancement image quality using a deep learning–based reconstruction algorithm and its influence on myocardial scar quantification
van der Velde, N., Hassing, H. C., Bakker, B. J., Wielopolski, P. A., Lebel, R. M., Janich, M., Kardys, I., Budde, R. P. J., & Hirsch, A. (2020) · European Radiology · doi:10.1007/s00330-020-07461-w · Cited by 73
Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy
Shiozaki, A. A., Senra, T., Arteaga, E., Filho, M. M., Pita, C. G., Ávila, L. F., Filho, J. R. P., Mady, C., Filho, R. K., Bluemke, D. A., et al. (2013) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2013.04.002 · Cited by 72
Microvascular Dysfunction, Myocardial Ischemia, and Progression to Heart Failure in Patients with Hypertrophic Cardiomyopathy
Cecchi, F., Sgalambro, A., Baldi, M., Sotgia, B., Antoniucci, D., Camici, P. G., Sciagrà, R., & Olivotto, I. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9142-5 · Cited by 72
The Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Prinz, C., Farr, M., Hering, D., Horstkotte, D., & Faber, L. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0209 · Cited by 72
Left Ventricular Outflow Tract Obstruction as a Risk Factor for Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Efthimiadis, G. K., Parcharidou, D. G., Giannakoulas, G. A., Pagourelias, E. D., Charalampidis, P. E., Savvopoulos, G., Ziakas, A., Karvounis, H. I., Stylıadis, I., & Parcharidis, G. E. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.039 · Cited by 70
Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy
McLellan, A. J. A., Ellims, A., Prabhu, S., Voskoboinik, A., Iles, L., Hare, J., Kaye, D. M., Macciocca, I., Mariani, J. A., Kalman, J. M., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12948 · Cited by 71
Cardiovascular Magnetic Resonance Imaging of Myocardial Infarction, Viability, and Cardiomyopathies
West, A. M., & Kramer, C. M. (2010) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2009.12.002 · Cited by 69
CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
Papavassiliu, T., Germans, T., Flüchter, S., Doesch, C., Suriyakamar, A., Haghi, D., Süselbeck, T., Wolpert, C., Dinter, D. J., Schoenberg, S. O., et al. (2009) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-11-34 · Cited by 69
Myocardial Fibrosis Severity on Cardiac Magnetic Resonance Imaging Predicts Sustained Arrhythmic Events in Hypertrophic Cardiomyopathy
Prinz, C., Schwarz, M., Ilić, I., Laser, K. T., Lehmann, R., Prinz, E., Bitter, T., Vogt, J., van Buuren, F., Bogunović, N., et al. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.05.004 · Cited by 68
Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy
Maron, B. J., Rowin, E. J., & Maron, M. S. (2019) · Circulation Research · doi:10.1161/circresaha.119.315159 · Cited by 68
Self-citation
Relationship of Delayed Enhancement by Magnetic Resonance to Myocardial Perfusion by Positron Emission Tomography in Hypertrophic Cardiomyopathy
Bravo, P. E., Zimmerman, S. L., Luo, H.-C., Pozios, I., Rajaram, M., Pinheiro, A. C., Steenbergen, C., Kamel, I. R., Wahl, R. L., Bluemke, D. A., et al. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.000110 · Cited by 67
Significance of Magnetic Resonance Imaging in Apical Hypertrophic Cardiomyopathy
Fattori, R., Biagini, E., Lorenzini, M., Buttazzi, K., Lovato, L., & Rapezzi, C. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.020 · Cited by 67
Cardiac MR Imaging of Nonischemic Cardiomyopathies: Imaging Protocols and Spectra of Appearances
O’Donnell, D., Abbara, S., Chaithiraphan, V., Yared, K., Killeen, R. P., Martos, R., Keane, D., Cury, R. C., & Dodd, J. D. (2012) · Radiology · doi:10.1148/radiol.11100284 · Cited by 66
The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy
Rowin, E. J., & Maron, M. S. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:13:3 · Cited by 67
Self-citation
Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy
Ismail, T. F., Prasad, S. K., & Pennell, D. J. (2011) · Heart · doi:10.1136/heartjnl-2011-300814 · Cited by 62
Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy
Almaas, V. M., Haugaa, K. H., Strøm, E. H., Scott, H., Dahl, C. P., Leren, T. P., Geiran, O. R., Endresen, K., Edvardsen, T., Aakhus, S., et al. (2013) · EP Europace · doi:10.1093/europace/eut028 · Cited by 62
Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
Aquaro, G. D., Positano, V., Pingitore, A., Strata, E., Bella, G. D., Formisano, F., Spirito, P., & Lombardi, M. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-21 · Cited by 61
The Future of Cardiovascular Imaging
Carli, M. F. D., Geva, T., & Davidoff, R. (2016) · Circulation · doi:10.1161/circulationaha.116.023511 · Cited by 59
Cardiovascular Magnetic Resonance Characteristics in Children With Hypertrophic Cardiomyopathy
Chaowu, Y., Zhao, S., Ling, J., Li, L., & Fang, W. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000414 · Cited by 59
The Remarkable 50 Years of Imaging in HCM and How it Has Changed Diagnosis and Management
Maron, B. J., & Maron, M. S. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.05.003 · Cited by 59
Self-citation
Sudden Death in the Young: Information for the Primary Care Provider
Erickson, C. C., Salerno, J. C., Berger, S., Campbell, R., Cannon, B. C., Christiansen, J., Moffatt, K. A., Pflaumer, A., Snyder, C. S., Srinivasan, C., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2021-052044 · Cited by 60
Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association
Fogel, M. A., Anwar, S., Broberg, C. S., Browne, L. P., Chung, T., Johnson, T. R., Muthurangu, V., Taylor, M. D., Valsangiacomo-Buechel, E., & Wilhelm, C. M. (2022) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.122.014415 · Cited by 60
Non Sustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy and New Ultrasonic Derived Parameters
Salvo, G. D., Pacileo, G., Limongelli, G., Baldini, L., Rea, A., Verrengia, M., D’Andrea, A., Russo, M. G., & Calabrò, R. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.02.013 · Cited by 61
Modern Imaging Techniques in Cardiomyopathies
Jan, M. F., & Tajik, A. J. (2017) · Circulation Research · doi:10.1161/circresaha.117.309600 · Cited by 64
Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge
Weissler‐Snir, A., Adler, A., Williams, L. K., Gruner, C., & Rakowski, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw268 · Cited by 59
Cardiovascular magnetic resonance imaging: what the general cardiologist should know
Ripley, D. P., Musa, T. A., Dobson, L. E., Plein, S., & Greenwood, J. P. (2016) · Heart · doi:10.1136/heartjnl-2015-307896 · Cited by 57
The cardiomyopathy in Friedreich's ataxia — New biomarker for staging cardiac involvement
Weidemann, F., Liu, D., Hu, K., Florescu, C., Niemann, M., Herrmann, S., Kramer, B., Klebe, S., Doppler, K., Üçeyler, N., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.074 · Cited by 59
Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study
Petri, H., Ahtarovski, K. A., Vejlstrup, N. G., Vissing, J., Witting, N., Køber, L., & Bundgaard, H. (2014) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/preaccept-1991790702125713 · Cited by 55
MRI findings of radiation-induced myocardial damage in patients with oesophageal cancer
Umezawa, R., Ota, H., Takanami, K., Ichinose, A., Matsushita, H., Saito, H., Takase, K., & Jingu, K. (2014) · Clinical Radiology · doi:10.1016/j.crad.2014.08.010 · Cited by 54
Abnormal T2-STIR Magnetic Resonance in Hypertrophic Cardiomyopathy: A Marker of Advanced Disease and Electrical Myocardial Instability
Todiere, G., Pisciella, L., Barison, A., Franco, A. D., Zachara, E., Piaggi, P., Re, F., Pingitore, A., Emdin, M., Lombardi, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111366 · Cited by 52
Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy
Konno, T., Chen, D., Wang, L., Wakimoto, H., Teekakirikul, P., Nayor, M. G., Kawana, M., Eminaga, S., Gorham, J., Pandya, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012826107 · Cited by 52
Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice
Elliot, P. M., & Spirito, P. (2008) · Heart · doi:10.1136/hrt.2008.154385 · Cited by 52
Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis
Shafee, M. A., Fukuda, K., Wakayama, Y., Nakano, M., Kondo, M., Hasebe, Y., Kawana, A., & Shimokawa, H. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.08.002 · Cited by 51
Prognostic Significance of Plasma High‐Sensitivity C‐Reactive Protein in Patients With Hypertrophic Cardiomyopathy
Zhu, L., Zou, Y., Wang, Y., Luo, X., Sun, K., Wang, H., Jia, L., Liu, Y., Zou, J., Yuan, Z., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004529 · Cited by 51
Usefulness of Delayed Enhancement by Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy as a Marker of Disease and Its Severity
Aquaro, G. D., Masci, P. G., Formisano, F., Barison, A., Strata, E., Pingitore, A., Positano, V., Spirito, P., & Lombardi, M. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.09.045 · Cited by 48
Imaging Phenotype Versus Genotype in Hypertrophic Cardiomyopathy
Desai, M. Y., Ommen, S. R., McKenna, W. J., Lever, H. M., & Elliot, P. M. (2011) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.957936 · Cited by 50
Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy
Pozios, I., Corona‐Villalobos, C. P., Sorensen, L. L., Bravo, P. E., Canepa, M., Pisanello, C., Pinheiro, A. C., Dimaano, V. L. J., Luo, H., Dardari, Z., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.06.018 · Cited by 47
Prognostic significance of cardiac magnetic resonance imaging: Update 2010.
Hombach, V., Merkle, N., Bernhard, P., Rasche, V., & Rottbauer, W. (2010) · PubMed · Cited by 47
The Prognostic Implications of Cardiovascular Magnetic Resonance
Flett, A. S., Westwood, M. A., Davies, C., Mathur, A., & Moon, J. (2009) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.840975 · Cited by 47
Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy — comparison with late enhancement quantification
Małek, Ł. A., Werys, K., Kłopotowski, M. M., Śpiewak, M., Miłosz‐Wieczorek, B., Mazurkiewicz, Ł., Petryka, J., Marczak, M., & Witkowski, A. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.04.001 · Cited by 46
Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy
Masci, P. G., Barison, A., Aquaro, G. D., Pingitore, A., Mariotti, R., Balbarini, A., Passino, C., Lombardi, M., & Emdin, M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.11.005 · Cited by 45
Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy
Choi, H., Kim, K., Lee, J. M., Yoon, Y. E., Lee, S., Park, E., Lee, W., Kim, Y.-J., Cho, G., Sohn, D., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-306555 · Cited by 45
Hypertrophic Cardiomyopathy
Ho, C. Y. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.12.001 · Cited by 49
Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9147-0 · Cited by 46
Self-citation
MRI of Nonischemic Cardiomyopathy
Bluemke, D. A. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4222 · Cited by 45
Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment
Jacoby, D. L., DePasquale, E. C., & McKenna, W. J. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.120138 · Cited by 44
Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias
Katritsis, D. G., Siontis, G. C. M., & Camm, A. J. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.07.005 · Cited by 44
Mechanical dispersion and global longitudinal strain by speckle tracking echocardiography: Predictors of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy
Candan, Ö., Geçmen, Ç., Bayam, E. M., Güner, A., Çelık, M., & Doğan, C. (2017) · Echocardiography · doi:10.1111/echo.13547 · Cited by 43
Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: Comparison with multislice CT
Yajima, R., Kataoka, A., Takahashi, A., Uehara, M., Saito, M., Yamaguchi, C., Lee, K. H., Komuro, I., & Funabashi, N. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.01.096 · Cited by 38
Long-term Outcomes of Ventricular Tachycardia Ablation in Different Types of Structural Heart Disease
Liang, J. J., Santangeli, P., & Callans, D. J. (2015) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2015.4.3.177 · Cited by 43
Myocardial Native T1 Time in Patients With Hypertrophic Cardiomyopathy
Kato, S., Nakamori, S., Bellm, S., Jang, J., Basha, T., Maron, M. S., Manning, W. J., & Nezafat, R. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.010 · Cited by 40
Self-citation
Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy
Kwieciński, J., Lennen, R. J., Gray, G. A., Borthwick, G., Boswell, L., Baker, A. H., Newby, D. E., Dweck, M. R., & Jansen, M. A. (2020) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-020-00655-7 · Cited by 41
T1 mapping for detection of left ventricular myocardial fibrosis in hypertrophic cardiomyopathy: A preliminary study
Lu, M., Zhao, S., Yin, G., Jiang, S., Zhao, T., Chen, X., Tian, L., Zhang, Y., Wei, Y.-Q., Liu, Q., et al. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2012.12.014 · Cited by 39
Cardiac Magnetic Resonance Imaging Findings Predict Major Adverse Events in Apical Hypertrophic Cardiomyopathy
Hanneman, K. A., Crean, A. M., Williams, L. K., Moshonov, H., James, S., Jiménez‐Juan, L., Gruner, C., Sparrow, P. J., Rakowski, H., & Nguyen, E. T. (2014) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000115 · Cited by 39
Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy
Ramchand, J., Wallis, M., Macciocca, I., Lynch, E. L., Farouque, O., Martyn, M. M., Phelan, D., Chong, B., Lockwood, S. M., Weintraub, R. G., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013346 · Cited by 40
Differentiating Exercise-Induced Cardiac Adaptations From Cardiac Pathology: The “Grey Zone” of Clinical Uncertainty
Kim, J. H., & Baggish, A. L. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.11.025 · Cited by 40
Implanted Defibrillators in Young Hypertrophic Cardiomyopathy Patients: A Multicenter Study
Kamp, A. N., Bergen, N. H. V., Henrikson, C. A., Makhoul, M., Saarel, E. V., LaPage, M. J., Russell, M. W. W., Strieper, M. J., Yu, S., Dick, M., et al. (2013) · Pediatric Cardiology · doi:10.1007/s00246-013-0676-6 · Cited by 38
Longitudinal Left Ventricular Strain in Hypertrophic Cardiomyopathy: Correlation with Nonsustained Ventricular Tachycardia
Correia, E., Rodrigues, B., dos Santos, L. F., Moreira, D., Gama, P., Cabral, C., & Santos, O. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2011.01427.x · Cited by 38
Contrast-Enhanced CMR in HCM
Maron, M. S. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.10.028 · Cited by 38
Self-citation
Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging
Berliner, J. I., Kino, A., Carr, J., Bonow, R. O., & Choudhury, L. (2012) · International journal of cardiac imaging · doi:10.1007/s10554-012-0048-y · Cited by 37
LncRNA‐MIAT regulates fibrosis in hypertrophic cardiomyopathy (HCM) by mediating the expression of miR‐29a‐3p
Zhou, J., Zhou, Y., & Wang, C. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28001 · Cited by 38
Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: For Which Patients?
Achim, A., Șerban, A. M., Mot, S. D. C., Leibundgut, G., Marc, M., & Sigwart, U. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14272 · Cited by 37
Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy
Windram, J. D., Benson, L. N., Dragelescu, A., Yoo, S., Mertens, L., Wong, D., & Grosse‐Wortmann, L. (2015) · Congenital Heart Disease · doi:10.1111/chd.12286 · Cited by 37
Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: A cardiac magnetic resonance imaging study
Pujadas, S., Vidal-Pérez, R., Hidalgo, A., Leta, R., Carreras, F., Barros, A., Bayés‐Genís, A., Subirana, M., & Pons‐Lladó, G. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.12.012 · Cited by 37
Prognostic Value of Contrast-enhanced Cardiac Magnetic Resonance Imaging in Patients with Newly Diagnosed Non-Ischemic Cardiomyopathy: Cohort Study
Müller, K., Müller, I. I., Krämer, U., Kandolf, R., Gawaz, M., Bauer, A., & Zuern, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057077 · Cited by 36
2014 Korean Guidelines for Appropriate Utilization of Cardiovascular Magnetic Resonance Imaging: A Joint Report of the Korean Society of Cardiology and the Korean Society of Radiology
Yoon, Y. E., Hong, Y. J., Kim, H., Kim, J., Na, J. O., Yang, D. H., Kim, Y. J., & Choi, E. (2014) · Korean Journal of Radiology · doi:10.3348/kjr.2014.15.6.659 · Cited by 36
Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy
Brenes, J. C., Doltra, A., & Prat, S. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.22 · Cited by 36
Magnetic Resonance Imaging of Cardiovascular Fibrosis and Inflammation: From Clinical Practice to Animal Studies and Back
Doltra, A., Stawowy, P., Dietrich, T., Schneeweis, C., Fleck, E., & Kelle, S. (2013) · BioMed Research International · doi:10.1155/2013/676489 · Cited by 35
Advances in cardiac imaging: the role of magnetic resonance imaging and computed tomography in identifying athletes at risk
Prakken, N. H. J., Velthuis, B. K., Cramer, M. J., & Mosterd, A. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.054767 · Cited by 34
T1 mapping in children and young adults with hypertrophic cardiomyopathy
Parekh, K., Markl, M., Deng, J., de Freitas, R. A., & Rigsby, C. K. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0979-9 · Cited by 35
ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy
Trivedi, A. D., & Knight, B. P. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:30:2 · Cited by 34
The Prognostic Role of Late Gadolinium Enhancement Magnetic Resonance Imaging in Patients With Cardiomyopathy
Stirrat, J., & White, J. A. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.11.033 · Cited by 33
Fragmented QRS Predicts Heart Failure Progression in Patients With Hypertrophic Cardiomyopathy
Nomura, A., Konno, T., Fujita, T., Tanaka, Y., Nagata, Y., Tsuda, T., Hodatsu, A., Sakata, K., Nakamura, H., Kawashiri, M., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0822 · Cited by 33
Circulating Matrix Metalloproteinases in Adolescents With Hypertrophic Cardiomyopathy and Ventricular Arrhythmia
Zachariah, J. P. V., Colan, S. D., Lang, P., Triedman, J. K., Alexander, M. E., Walsh, E. P., Berul, C. I., & Cecchin, F. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.966200 · Cited by 33
Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy
Amano, Y., Suzuki, Y., Yanagisawa, F., Omori, Y., & Matsumoto, N. (2018) · BioMed Research International · doi:10.1155/2018/4092469 · Cited by 31
High Risk of Sustained Ventricular Arrhythmia Recurrence After Acute Myocarditis
Rosier, L., Zouaghi, A., Barré, V., Martins, R. P., Probst, V., Marijon, É., Sadoul, N., Chauveau, S., Costa, A. D., Badoz, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030848 · Cited by 33
Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy
Jenab, Y., Pourjafari, M., Darabi, F., Boroumand, M. A., Zoroufian, A., & Jalali, A. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.07.008 · Cited by 32
LGE Means Better Selection of HCM Patients for Primary Prevention Implantable Defibrillators ∗
Maron, B. J., & Maron, M. S. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.01.032 · Cited by 33
Self-citation
Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
Strijack, B., Ariyarajah, V., Soni, R. N., Jassal, D. S., Greenberg, C. R., McGregor, R., & Morris, A. L. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-58 · Cited by 32
Cardiovascular Magnetic Resonance Imaging and Heart Failure
Liu, C., Ferrari, V. A., & Han, Y. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01464-9 · Cited by 35
Cardiovascular Magnetic Resonance Imaging
Kwong, R. Y. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-306-6 · Cited by 32
Cardiac MRI and CT features of inheritable and congenital conditions associated with sudden cardiac death
Sparrow, P. J., Merchant, N., Provost, Y. L., Doyle, D. J., Nguyen, E. T., & Paul, N. S. (2008) · European Radiology · doi:10.1007/s00330-008-1169-5 · Cited by 31
Cardiovascular MRI Predicts 5-Year Adverse Clinical Outcome in Heart Transplant Recipients
Butler, C., Kim, D. H., Chow, K., Toma, M., Thompson, R. B., Mengel, M., Haykowsky, M. J., Pearson, G. J., & Paterson, D. I. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12811 · Cited by 31
The Current and Emerging Role of Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy
Maron, M. S. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9136-3 · Cited by 31
Self-citation
Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer
Lawley, C. M., Wainwright, C., Segelov, E., Lynch, J., Beith, J. M., & McCrohon, J. A. (2012) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2011.01462.x · Cited by 30

Authors: Adabag, A. S., Maron, B. J., Appelbaum, E., Harrigan, C. J., Buros, J. L., Gibson, C. M., Lesser, J. R., Hanna, C. A., Udelson, J. E., Manning, W. J., & Maron, M. S.
Affiliations: Minneapolis Heart Institute Foundation (US)
Beth Israel Deaconess Medical Center (US)
Harvard University (US)
Tufts Medical Center (US)
ORCID: Maron, Barry J.
Buros, Jacqueline L.
Gibson, C. Michael
Lesser, John R.
Udelson, James E.
Manning, Warren J.
Maron, Martin S.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2008-04
Volume: 51
Issue: 14
Pages: 1369-1374
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2007.11.071
OpenAlex: W2076526672
Cited by: 662
References: 43
Citations by year: 2026: 10 · 2025: 12 · 2024: 12 · 2023: 14 · 2022: 15 · 2021: 24 · 2020: 24 · 2019: 28 · 2018: 32 · 2017: 29 · 2016: 39 · 2015: 42 · 2014: 64 · 2013: 48 · 2012: 60
FWCI: 50.64
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1932 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: Clinical Science Research and Development
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, myocardial fibrosis, late gadolinium enhancement, cardiovascular magnetic resonance, ventricular arrhythmias, non-sustained ventricular tachycardia, premature ventricular contractions, arrhythmogenic substrate, Holter monitoring, asymptomatic patients, arrhythmic risk stratification, contrast-enhanced MRI, cardiac resynchronization therapy, implantable cardioverter-defibrillator
MeSH terms: Adolescent, Adult, Aged, Cardiomyopathy, Hypertrophic, Female, Fibrosis, Health Status Indicators, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Tachycardia, Time Factors, Prevalence, Risk Assessment, Blood Pressure Monitoring, Ambulatory, Ventricular Premature Complexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks